November 2014 Vol XXXVIII Issue 11
GASTROINTESTINAL MOTILITY AND FUNCTIONAL BOWEL DISORDERS, #3
Superior Mesenteric Artery SyndromeThe recognition of Superior Mesenteric Artery Syndrom (SMA) as a distinct clinical entity remains controversial because it can be confused with other anatomic or motility- related causes of duodenal obstruction. It was often regarded as a diagnostic dilemma and a diagnosis of exclusion. In this article we will review the pathophysiology, symptoms, diagnosis and treatment of SMA syndrome.
GERD IN THE 21st CENTURY, SERIES #24
Circadian Reflux Pattern on PPI TherapyProton pump inhibitor (PPI) therapy has become the standard treatment for patients with GERD. The normal circadian pattern of intragastric acidity is an increase in acid secretion beginning in the evening until midnight. The circadian pattern for esophageal reflux is largely unknown. The aim of this study was to analyze the circadian pattern of both acid and non-acid reflux and the effect of PPI therapy.
NUTRITION ISSUES IN GASTROENTEROLOGY, SERIES #135
Celebrating the Holidays: A “Fresh” Look at Holiday Foods for Those with DysphagiaDysphagia may result from a disease process, surgery, trauma, dental work, or congenital problem affecting any aspect of the swallowing process from the mouth to the esophagus. In this article, we outline recipes and how-to tips to prepare soft, moist foods, so that patients living with dysphagia will once again be able to experience the joy associated with holiday eating.
A CASE REPORT
Perivascular Epithelioid Cell Neoplasm (PEComa) as a Cause of Abdominal Pain in a ChildConference Digest November 2014
Practical Gastroenterology is excited to bring you this special supplement featuring abstract highlights and author insights from the American College of Gastroenterology’s 2014 Annual Scientific Meeting. Among the inflammatory bowel disease-related abstracts, we include those which focus on pregnancy, quality of life issues, treatment options and the importance of colonoscopy surveillance. The abstract highlights and author insights below first appeared on the ACG Blog and were selected by the ACG Educational Affairs and PR Committees as newsworthy.
Departments Section
Use of Biologics in Pediatric Crohn’s Disease
Biologic therapy using anti-tumor necrosis factor alpha (anti-TNF alpha) agents is part of the arsenal of care for children with Crohn’s disease (CD), but it is difficult to obtain data on the effectiveness of this drug class in the pediatric age range. In 2007, a United States national quality improvement collaborative, known as ImproveCareNow, was developed as a learning health system for pediatric inflammatory bowel disease (IBD).
Nutritional Outcomes and Pancreatic Enzyme Replacement in Cystic Fibrosis
Nutrition in a cornerstone for cystic fibrosis (CF) care as good nutritional outcome correlates with pulmonary function in the pediatric population. Pediatric enzyme replacement therapy (PERT) is needed in CF patients to help overcome exocrine pancreatic insufficiency, improve fat absorption, and improve weight gain. The authors of this study evaluated PERT dosing as a potential marker of pediatric CF nutritional status.
STERIS ANNOUNCES LAUNCH OF LATEST INNOVATION IN VAPORIZED HYDROGEN PEROXIDE TECHNOLOGY
MENTOR, OHIO - STERIS Corporation, a leader in hydrogen peroxide sterilization, has announced the launch of the V-PRO® 60 Low Temperature Sterilization System, its latest innovative advance for today’s challenging healthcare market. This product provides healthcare professionals with the most productive and cost-effective solution for reprocessing heat and moisture-sensitive devices.
December 4 – 6, 2014
Advances in Inflammatory Bowel Diseases, Crohn’s & Colitis Foundation’s Clinical & Research Conference
Digestive Disease Week May 16-19, 2015
Exhibit Dates: May 17-19
